OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

In Annex I to Directive 91/414/EEC, the following rows are added at the end of the table:

Further details on identity and specification of active substances are provided in the review report.

NoCommon name, identification numbersIUPAC namePurityf1 Entry into forceExpiration of inclusionSpecific provisions
‘306

Penoxsulam

CAS No 219714-96-2

CIPAC No 758

3-(2,2-difluoroethoxy)-N-(5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-α,α,α-trifluorotoluene-2-sulfonamide

> 980 g/kg

The impurity

Bis-CHYMP

2-chloro-4-[2-(2-chloro-5-methoxy-4-pyrimidinyl)hydrazino]-5-methoxypyrimidine must not exceed 0,1 g/kg in the technical material

1 August 201031 July 2020

PART A

Only uses as herbicide may be authorised.

PART B

For the implementation of the uniform principles of Annex VI, the conclusions of the review report on penoxsulam, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2010 shall be taken into account.

In this overall assessment, Member States must pay particular attention to:

  • the protection of aquatic organisms,

  • the dietary exposure of consumers to residues of the metabolite BSCTA in succeeding rotational crops,

  • the protection of groundwater when the active substance is applied in regions with vulnerable soil and/or climatic conditions.

Conditions of authorisation shall include risk mitigation measures, where appropriate.

The Member States concerned shall ensure that the notifier submits to the Commission further information to address the off-field risk to higher aquatic plants. They shall ensure that the notifier provides such information to the Commission by 31 July 2012.

The Rapporteur Member State shall inform the Commission in accordance with Article 13(5) on the specification of the technical material as commercially manufactured.

307

Proquinazid

CAS No 189278-12-4

CIPAC No 764

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one > 950 g/kg1 August 201031 July 2020

PART A

Only uses as fungicide may be authorised.

PART B

For the implementation of the uniform principles of Annex VI, the conclusions of the review report on proquinazid, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2010 shall be taken into account.

In this overall assessment, Member States must pay particular attention:

  • to the long-term risk to earthworm-eating birds for uses in grapevine,

  • to the risk to aquatic organisms,

  • the dietary exposure of consumers to proquinazid residues in products of animal origin and in succeeding rotational crops,

  • to the operator safety.

Conditions of authorisation shall include risk mitigation measures, where appropriate.

The Rapporteur Member State shall inform the Commission in accordance with Article 13(5) on the specification of the technical material as commercially manufactured.

308

Spirodiclofen

CAS No 148477-71-8

CIPAC No 737

3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate

> 965 g/kg

The following impurities must not exceed a certain amount in the technical material:

3-(2,4-dichlorophenyl)-4-hydroxy-1-oxaspiro[4.5]dec-3-en-2-one (BAJ-2740 enol): ≤ 6 g/kg

N,N-dimethylacetamide: ≤ 4 g/kg

1 August 201031 July 2020

PART A

Only uses as acaricide or insecticide may be authorised.

PART B

For the implementation of the uniform principles of Annex VI, the conclusions of the review report on spirodiclofen, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2010 shall be taken into account.

In this overall assessment, Member States must pay particular attention:

  • to the long-term risk to aquatic organisms,

  • to the operator safety,

  • to the risk to bee brood.

Conditions of authorisation shall include risk mitigation measures, where appropriate.’

Annotations

Footnotes

f1

Further details on identity and specification of active substances are provided in the review report.